Pharmacovigilance and Drug Safety

The pharmacovigilance is related to collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products, and it is needed in different stages of product life cycle, and the safety surveillance and risk management. Information received from patients and healthcare providers via pharmacovigilance agreements, plays a critical role in providing the data necessary for Pharmacovigilance to take place, in order to market or to test a pharmaceutical product, adverse event data must be submitted to the local drug regulatory authority. Finally pharmacovigilance is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that may come to patients by safety surveillance and risk management

 

  • Nutrigenomics
  • Translational pharmacogenomics
  • Challenges to pharmacogenomics
  • Biomarker translation and testing
  • Molecular-targeted interventions including gene therapy

Related Conference of Pharmacovigilance and Drug Safety

September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
December 14-15, 2026

5th Global Summit on Pharmaceutical Research

Paris, France
January 26-27, 2027

22nd Annual Meet on Pharmaceutical Sciences

Paris, France
February 15-16, 2027

23rd Annual Congress on Pharmacology and Toxicology

Paris, France
April 08-09, 2027

21st World Drug Delivery Summit

Vienna, Austria
April 27-28, 2027

10th European Biopharma Congress

Paris, France
April 27-28, 2027

19th World Drug Delivery Summit

Paris, France

Pharmacovigilance and Drug Safety Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in